Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of NVO Novo Nordisk A/S | 58.7% in 12m

Compare NVO with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Novo Nordisk A/S with its related Sector/Index XLV

Compare Novo Nordisk A/S with its related Sector/Index XLV

Performance Duell NVO vs XLV

TimeFrame NVO XLV
1 Day -0.88% 0.56%
1 Week -3.66% 1.41%
1 Month -11.8% 2.64%
3 Months -0.09% 7.56%
6 Months 17.9% 8.49%
12 Months 58.7% 13.60%
YTD 24.8% 8.87%
Rel. Perf. 1m -1.37
Rel. Perf. 3m -0.61
Rel. Perf. 6m 0.72
Rel. Perf. 12m 0.72

Is Novo Nordisk A/S a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, Novo Nordisk A/S (NYSE:NVO) is currently (July 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 79.86 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NVO as of July 2024 is 159.81. This means that NVO is currently undervalued and has a potential upside of +26.1% (Margin of Safety).

Is NVO a buy, sell or hold?

  • Strong Buy: 5
  • Buy: 4
  • Hold: 1
  • Sell: 0
  • Strong Sell: 1
Novo Nordisk A/S has received a consensus analysts rating of 4.09. Therefor, it is recommend to buy NVO.
Values above 0%: NVO is performing better - Values below 0%: NVO is underperforming

Compare NVO with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -2.83% -11.59% 5.46% 38.09%
US NASDAQ 100 QQQ -1.08% -8.17% 8.31% 37.18%
US Dow Jones Industrial 30 DIA -4.41% -15.60% 10.41% 42.41%
German DAX 40 DBXD -5.05% -13.23% 9.77% 43.82%
UK FTSE 100 ISFU -4.85% -14.40% 6.32% 43.51%
Shanghai Shenzhen CSI 300 CSI 300 -0.66% -11.49% 15.75% 74.27%
Hongkong Hang Seng HSI -2.24% -11.01% 21.87% 78.69%
Japan Nikkei 225 EXX7 -2.15% -10.64% 16.33% 47.77%
India NIFTY 50 INDA -4.80% -14.69% 2.36% 31.74%
Brasil Bovespa EWZ -2.73% -13.18% 32.00% 71.08%

NVO Novo Nordisk A/S vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -2.00% -9.16% 9.54% 35.75%
Consumer Discretionary XLY -0.89% -11.40% 11.04% 52.74%
Consumer Staples XLP -4.17% -13.40% 8.18% 52.00%
Energy XLE -3.47% -13.56% 6.68% 49.77%
Financial XLF -4.97% -17.62% 4.69% 33.69%
Health Care XLV -5.07% -14.43% 9.38% 45.08%
Industrial XLI -4.81% -15.58% 5.80% 42.45%
Materials XLB -5.01% -14.88% 6.25% 49.97%
Real Estate XLRE -4.20% -19.66% 10.25% 48.19%
Technology XLK -1.58% -7.39% 10.30% 36.47%
Utilities XLU -5.14% -15.25% -0.31% 48.93%
Aerospace & Defense XAR -7.30% -17.48% 2.79% 38.95%
Biotech XBI -7.79% -21.93% 2.65% 38.05%
Homebuilder XHB -7.95% -27.79% -5.94% 19.34%
Retail XRT -5.75% -14.42% 6.76% 43.19%

NVO Novo Nordisk A/S vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -1.24% -8.44% 13.75% 54.66%
Natural Gas UNG 1.86% 14.43% 50.79% 111.18%
Gold GLD -3.16% -15.58% -0.11% 37.69%
Silver SLV 0.87% -8.64% -4.28% 46.38%
Copper CPER -1.12% -6.46% 10.75% 55.01%

Returns of NVO vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -3.74% -11.94% 16.73% 62.09%
iShares High Yield Corp. Bond HYG -4.06% -13.68% 13.85% 48.52%
Does Novo Nordisk A/S outperform its market, is NVO a Sector Leader?
Yes, over the last 12 months Novo Nordisk A/S (NVO) made 58.68%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.60%.
Over the last 3 months NVO made -0.09%, while XLV made 7.56%.
Period NVO XLV S&P 500
1 Month -11.79% 2.64% -0.20%
3 Months -0.09% 7.56% 7.46%
12 Months 58.68% 13.60% 20.59%